TransBiotec, Inc. (IMLE) financial statements (2020 and earlier)

Company profile

Business Address 885 ARAPAHOE ROAD
BOULDER, CO 80302
State of Incorp. DE
Fiscal Year End December 31
SIC 2721 - Periodicals: Publishing, or Publishing and Printing (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments13001481 
Cash and cash equivalents13001481 
Receivables(1,404)1,3471,196    
Prepaid expense9133    
Other undisclosed current assets1,404(1,347)(1,196)    
Total current assets:231331481 
Noncurrent Assets
Property, plant and equipment     01
Total noncurrent assets:     01
TOTAL ASSETS:2313314811
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,2391,150653653805484422
Accounts payable189192271350622484422
Accrued liabilities420421     
Interest and dividends payable630537382303183  
Debt230164164164157872612
Derivative instruments and hedges, liabilities53      
Due to related parties8972,1221,6571,739902  
Other undisclosed current liabilities67614934712981,6971,447
Total current liabilities:3,0943,4372,9673,0262,1623,0532,481
Noncurrent Liabilities
Long-term debt and lease obligation     43167
Long-term debt, excluding current maturities     43167
Total noncurrent liabilities:     43167
Total liabilities:3,0943,4372,9673,0262,1623,0962,648
Stockholders' equity
Stockholders' equity attributable to parent, including:(3,072)(3,423)(2,964)(3,012)(2,155)(3,095)(2,647)
Common stock2111110
Common stock, value, subscriptions3     
Additional paid in capital15,75114,88814,78514,09514,35412,71712,416
Accumulated deficit(18,772)(18,262)(17,703)(17,064)(16,469)(15,777)(15,033)
Other undisclosed stockholders' equity attributable to parent(55)(50)(47)(44)(40)(35)(30)
Stockholders' equity attributable to noncontrolling interest(53)(50)   (35)(30)
Other undisclosed stockholders' equity1051014744407061
Total stockholders' equity:(3,019)(3,373)(2,917)(2,968)(2,115)(3,060)(2,617)
Other undisclosed liabilities and equity(53)(50)(47)(44)(40)(35)(30)
TOTAL LIABILITIES AND EQUITY:2313314811

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Operating expenses(312)(299)(313)(396)(447)(506)(785)
Operating loss:(312)(299)(313)(396)(447)(506)(785)
Nonoperating income (expense)(333)(263)(329)(203)(249)(243)21
Interest and debt expense258(5) 150(33)6
Loss from continuing operations before equity method investments, income taxes:(387)(567)(642)(584)(696)(782)(758)
Other undisclosed income (loss) from continuing operations before income taxes 5 (15)(0)33(6)
Loss from continuing operations before income taxes:(387)(562)(642)(599)(697)(749)(763)
Income tax expense (516)     
Other undisclosed loss from continuing operations(580)      
Loss before gain (loss) on sale of properties:(968)(1,079)(642)(599)(697)(749)(763)
Other undisclosed net loss(194)      
Net loss:(1,162)(1,079)(642)(599)(697)(749)(763)
Net income attributable to noncontrolling interest  34545
Other undisclosed net income attributable to parent515516     
Net loss available to common stockholders, diluted:(647)(562)(639)(595)(692)(745)(758)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(1,162)(1,079)(642)(599)(697)(749)(763)
Comprehensive loss:(1,162)(1,079)(642)(599)(697)(749)(763)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest  345(4)(5)
Other undisclosed comprehensive loss, net of tax, attributable to parent(2)      
Comprehensive loss, net of tax, attributable to parent:(1,164)(1,079)(639)(595)(692)(753)(768)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: